Oximio Kaynakları

NEWS • MAY 2023

Oximio announces its sponsorship of the Clinical Research Society of Kenya’s Inaugural Event

INSIGHTS • MAY 2023

Ministry of Health – Status of Clinical Trials in Ukraine 2022

NEWS • MAY 2023

Oximio Hungary Receives GMP and MIA Certification

NEWS • FEB 2023

Oximio Ukraine implements business continuity plan in response to war

CASE STUDY • FEB 2023

Clinical trials in Ukraine: a first-hand perspective​

NEWS • FEB 2023

Oximio Ukraine is represented at CTS Executive Board at EBA

NEWS • FEB 2023

Oximio support for Türkiye earthquake disaster

NEWS • JAN 2023

Oximio Israel excels in securing import licenses for unlicensed medication

NEWS • JAN 2023

Oximio expands patient centricity services in Israel

NEWS • DEC 2022

Mykola Nikolaiev appointed Chief Executive Officer

NEWS • MAR 2022

Oximio expands its Africa capability with a transit depot in Kenya

NEWS • FEB 2021

The SMO Group announces company name change to Oximio

INSIGHTS

Ensuring Uninterrupted Operations in Clinical Trials

INSIGHTS

Running Clinical Trials in Serbia – Quick Facts

Maximising Smart Warehousing as part of a Cold Chain Management Solution for Clinical Trials

INSIGHTS

Patient Centricity in Clinical Trials: Putting Patients First

INSIGHTS

Ensuring Data Integrity: Best Practices for Clinical Trial Security

INSIGHTS

Courier Services for Pharmaceutical, Biotech and Medical companies

INSIGHTS

Leveraging Technology in Clinical Trial Logistics

CASE STUDY

Delivering vital biospecimens from Ukraine to Europe in record time

INSIGHTS

Medical Cannabis and its Expanding Treatments